摘要
本研究的目的是探讨改变核转录因子的水平κBp65(NF-κBp65)、单核细胞化学引诱物蛋白1(MCP-1 / CCL-2)和巨噬细胞炎性蛋白- 1α(MIP-1α/ CCL-3)关系的表达α3烟碱乙酰胆碱受体(乙酰胆在阿尔茨海默病(AD)的发病机理。阿尔茨海默病和年龄的事后人脑控制个人,SH-SY5Y和U87MG细胞株暴露β-amyloid肽(Aβ),以及SH-SY5Y的细胞α3抑制了乙酰siRNA被用来研究可能的表达变化的目标如NF-κBp65 MCP-1,MIP-1αα3乙酰胆。免疫组织化学结果显示NF-κBp65免疫反应性的增加,MCP-1和MIP-1α神经元的大脑海马和颞叶和额叶区域的阿尔茨海默病。NF-κBp65水平,MCP-1 MIP-1α蛋白质和mRNA水平都显著上调SH-SY5Y和U87MG细胞暴露于Aβ1-42,虽然表明α3 Aβ1-42暴露SH-SY5Y细胞乙酰胆是衰减的。有趣的是,在SH-SY5Y细胞受到α3乙酰信使rna,NF-κBp65,MCP-1 MIP-1α升高。NF -κB和趋化因子的高表达可能参与表达减少α3乙酰胆在AD的发病机制。
关键词: 阿尔茨海默氏症、大脑、β-amyloid肽、NF-κBp65、MCP-1、MCP-1α、α3乙酰胆。
Current Alzheimer Research
Title:Elevations in the Levels of NF-κB and Inflammatory Chemotactic Factors in the Brains with Alzheimer’s Disease - One Mechanism May Involve α3 Nicotinic Acetylcholine Receptor
Volume: 13 Issue: 11
Author(s): Yuan Liao, Xiao-Lan Qi, Ying Cao, Wen-Feng Yu, Rivka Ravid, Bengt Winblad, Jin-Jing Pei, Zhi-Zhong Guan
Affiliation:
关键词: 阿尔茨海默氏症、大脑、β-amyloid肽、NF-κBp65、MCP-1、MCP-1α、α3乙酰胆。
摘要: The purpose of this study was to investigate the alterations in the levels of nuclear factor κBp65 (NF-κBp65), monocyte chemoattractant protein 1 (MCP-1/CCL-2) and macrophage inflammatory protein 1α (MIP-1α/CCL-3) in relationship to the expression of α3 nicotinic acetylcholine receptor (nAChR) during the pathogenesis of Alzheimer’s disease (AD). The post-mortem human brains of AD and age-matched control individuals, SH-SY5Y and U87MG cell lines exposed to β-amyloid peptide (Aβ), as well as the SH-SY5Y cells in which α3 nAChR was down-regulated by siRNA were used to study the possible expression changes of the targets such as NF-κBp65, MCP-1, MIP-1α and α3 nAChR. The immunohistochemistry results showed the increased immunoreactivities of NF-κBp65, MCP-1 and MIP-1α in neurons in hippocampal and temporal and frontal regions of AD brains. Levels of NF-κBp65, MCP-1 and MIP-1α at both protein and mRNA levels were all significantly up-regulated in SH-SY5Y and U87MG cells exposed to Aβ1-42, while expression of α3 nAChRs in Aβ1-42 exposed SH-SY5Y cells was attenuated. Interestingly, in the SH-SY5Y cells subjected to α3 nAChR mRNA silencing, expression of NF-κBp65, MCP-1 and MIP-1α was elevated. The elevated expressions of NF- κB and chemokines may be involved by decreased expression of α3 nAChRs during the pathogenesis of AD.
Export Options
About this article
Cite this article as:
Yuan Liao, Xiao-Lan Qi, Ying Cao, Wen-Feng Yu, Rivka Ravid, Bengt Winblad, Jin-Jing Pei, Zhi-Zhong Guan , Elevations in the Levels of NF-κB and Inflammatory Chemotactic Factors in the Brains with Alzheimer’s Disease - One Mechanism May Involve α3 Nicotinic Acetylcholine Receptor, Current Alzheimer Research 2016; 13 (11) . https://dx.doi.org/10.2174/1567205013666160703174254
DOI https://dx.doi.org/10.2174/1567205013666160703174254 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial [Hot Topic: Non-Reproductive Effects of Sex Steroids: Their Immunoregulatory Role (Guest Editor: Jorge Morales-Monto)]
Current Topics in Medicinal Chemistry The Role of Atrial Fibrosis Detected by Delayed - Enhancement MRI in Atrial Fibrillation Ablation
Current Medical Imaging Biomimetic Drug Delivery Systems Oriented by Biological Function in Tumor Targeting
Current Drug Targets Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders
Current Neurovascular Research Fullerene-like Nanoparticles of Titanium Disulfide
Current Nanoscience Magnesium and Anaesthesia
Current Drug Targets Editorial: Neurodegenerative Disorders: Synthesis, Drug Delivery Strategies and Biological Evaluation of New Therapeutic Agents
Central Nervous System Agents in Medicinal Chemistry Acknowledgement To Reviewers
Current Neuropharmacology From 9/11 To 2011: A Brief Overview from a Child and Adolescent Psychiatry Perspective
Adolescent Psychiatry Recent Advances Using Phosphodiesterase 4 (PDE4) Inhibitors to Treat Inflammatory Disorders: Animal and Clinical Studies
Current Drug Therapy Recent Progress and Related Patents on the Applications of Bone Marrow-Derived Stem/Progenitor Cells in Regenerative Medicine and Cancer Therapies
Recent Patents on Regenerative Medicine Inhibition of Brain Ischemia-Caused Notch Activation in Microglia May Contribute to Isoflurane Postconditioning-Induced Neuroprotection in Male Rats
CNS & Neurological Disorders - Drug Targets Synthesis, Characterization and Biological Activities of New Symmetric Bis-1,2,3-Triazoles with Click Chemistry
Medicinal Chemistry Natural Compounds Therapeutic Features in Brain Disorders by Experimental, Bioinformatics and Cheminformatics Methods
Current Medicinal Chemistry N-Terminal Specific Fluorescence Labeling and its Use in Local Structure Analysis of Proteins (Invited Review)
Current Chemical Biology Mitogenomics: Recognizing the Significance of Mitochondrial Genomic Variation for Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Adverse Bioeffects of Ultrasound Contrast Agents Used in Echocardiography: True Safety Issue or “Much Ado About Nothing”?
Current Vascular Pharmacology High Throughput Sonication: Evaluation for Compound Solubilization
Combinatorial Chemistry & High Throughput Screening Synthesis and Biological Activities of Sulfinyl Acetamide Derivatives for Narcolepsy Treatment
Letters in Drug Design & Discovery Neurodegeneration in Amygdala Precedes Hippocampus in the APPswe/ PS1dE9 Mouse Model of Alzheimer’s Disease
Current Alzheimer Research